NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (4932 d 17:03 ago) – Posting: # 5468
Views: 7,911

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.

If you investigate steady state PK you can do an "active washout" without interrupting treatment.


Kind regards and have a nice day

Complete thread:

UA Flag
 Admin contact
22,822 posts in 4,786 threads, 1,633 registered users;
22 visitors (0 registered, 22 guests [including 8 identified bots]).
Forum time: 06:27 CET (Europe/Vienna)

A scientist’s aim in a discussion with his colleagues
is not to persuade, but to clarify.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz